Intellectual Property
Dec. 5, 2011
Diagnostic tests face high court scrutiny
The U.S. Supreme Court is set to consider the validity of patents on certain diagnostic tests, the outcome of which could make or break some companies specializing in personalized medicine.
Daily Journal Staff Writer
The U.S. Supreme Court is set to consider the validity of patents on certain diagnostic tests, the outcome of which could make or break some companies specializing in personalized medicine.
If the high court rules that the patents are invalid, it could put in jeopardy the ability of companies to generate the revenue they need to develop new tests.
On Wednesday, justices will consider an is...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In